Compare ROAD & BIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ROAD | BIO |
|---|---|---|
| Founded | 2001 | 1952 |
| Country | United States | United States |
| Employees | N/A | 7450 |
| Industry | Engineering & Construction | Biotechnology: Laboratory Analytical Instruments |
| Sector | Industrials | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.3B | 6.9B |
| IPO Year | 2018 | N/A |
| Metric | ROAD | BIO |
|---|---|---|
| Price | $113.66 | $285.45 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 4 |
| Target Price | $127.80 | ★ $339.75 |
| AVG Volume (30 Days) | ★ 513.2K | 431.5K |
| Earning Date | 05-08-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 40.46 | N/A |
| EPS | ★ 0.47 | N/A |
| Revenue | ★ $785,679,000.00 | N/A |
| Revenue This Year | $27.79 | $2.74 |
| Revenue Next Year | $10.29 | $3.20 |
| P/E Ratio | $224.89 | ★ $9.72 |
| Revenue Growth | ★ 0.31 | N/A |
| 52 Week Low | $93.22 | $222.80 |
| 52 Week High | $151.00 | $343.12 |
| Indicator | ROAD | BIO |
|---|---|---|
| Relative Strength Index (RSI) | 49.38 | 47.20 |
| Support Level | $105.97 | $256.85 |
| Resistance Level | $124.14 | $288.48 |
| Average True Range (ATR) | 5.52 | 9.54 |
| MACD | -0.32 | -2.00 |
| Stochastic Oscillator | 55.80 | 1.12 |
Construction Partners Inc operates as a civil infrastructure company. It specializes in the construction and maintenance of roadways. The company through its subsidiaries, provides various products and services to both public and private infrastructure projects, with an emphasis on highways, roads, bridges, airports, and commercial and residential developments. Its operations consist of manufacturing and distributing hot mix asphalt, paving activities, including the construction of roadway base layers and application of asphalt pavement, site development, including the installation of utility and drainage systems, and others. The company has a single segment which predominantly consists of infrastructure and road construction, and operates across various states in the United States.
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.